Access Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Global Markets Direct
April 30, 2014
34 Pages - GMD12089
$1,500.00

Summary

Global Markets Direct’s, ‘Access Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Access Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Access Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Access Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Access Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Access Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Access Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Access Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Access Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Access Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Access Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Access Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Access Pharmaceuticals, Inc. Snapshot 5
Access Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Access Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Access Pharmaceuticals, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Access Pharmaceuticals, Inc. - Pipeline Products Glance 11
Access Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Access Pharmaceuticals, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Access Pharmaceuticals, Inc. - Unknown Stage Pipeline Products 13
Unknown Products/Combination Treatment Modalities 13
Access Pharmaceuticals, Inc. - Drug Profiles 14
AP-5346 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
CobaCyte Targeted Therapeutics For Oncology 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CobOral hGH 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CobOral Insulin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
GLP-1 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Oral Fertility Drugs 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Prolindaun 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
RNAi Therapeutics 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Access Pharmaceuticals, Inc. - Pipeline Analysis 23
Access Pharmaceuticals, Inc. - Pipeline Products by Target 23
Access Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 24
Access Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 25
Access Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 26
Access Pharmaceuticals, Inc. - Recent Pipeline Updates 27
Access Pharmaceuticals, Inc. - Dormant Projects 28
Access Pharmaceuticals, Inc. - Discontinued Pipeline Products 29
Discontinued Pipeline Product Profiles 29
Thiarabine 29
Access Pharmaceuticals, Inc. - Company Statement 30
Access Pharmaceuticals, Inc. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34

List of Tables
Access Pharmaceuticals, Inc., Key Information 5
Access Pharmaceuticals, Inc., Key Facts 5
Access Pharmaceuticals, Inc. - Pipeline by Indication, 2014 8
Access Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Access Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Access Pharmaceuticals, Inc. - Phase II, 2014 11
Access Pharmaceuticals, Inc. - Preclinical, 2014 12
Access Pharmaceuticals, Inc. - Unknown, 2014 13
Access Pharmaceuticals, Inc. - Pipeline by Target, 2014 23
Access Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 24
Access Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 25
Access Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 26
Access Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 27
Access Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 28
Access Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 29
Access Pharmaceuticals, Inc., Subsidiaries 32

List of Figures
Access Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014 7
Access Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Access Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Access Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014 23
Access Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014 24
Access Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014 25
Access Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 26

$1,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax